{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:15:41Z","timestamp":1788509741023,"version":"build-2803163510"},"reference-count":16,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"unspecified","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008816","name":"University of Sri Jayewardenepura","doi-asserted-by":"publisher","award":["RC\/URG\/MED\/2024\/53"],"award-info":[{"award-number":["RC\/URG\/MED\/2024\/53"]}],"id":[{"id":"10.13039\/501100008816","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,7,15]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Leptospirosis is a zoonotic infection caused by the bacterium\n                      <jats:italic>Leptospira,<\/jats:italic>\n                      which typically enters humans through contact with water or soil contaminated with infected urine. One of the most important causes of death due to leptospirosis is leptospirosis pulmonary haemorrhage syndrome (LPHS). LPHS occurs due to an inappropriate immune response, resulting in excessive release of cytokines\/chemokines or direct damage to alveoli by bacteria. Mortality remains high in LPHS, and management strategies of this deadly complication are under-investigated. Survivors have minimal residual lung injury, necessitating evidence-based treatment to improve mortality in LPHS. Steroids and plasmapheresis have been tried in many case series but lack robust evidence. Plasmapheresis has become a standard practice in Sri Lanka for managing LPHS, guided by expert opinion. This study will try to determine the effect of moderate-dose or high-dose steroid combination with plasmapheresis compared with plasmapheresis alone as a treatment for LPHS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      This open-label, randomised controlled trial will enrol LPHS patients from four selected tertiary care hospitals in Sri Lanka. Participants will be randomly assigned to three groups in a 1:1:1 ratio to receive plasmapheresis alone, plasmapheresis with 150\u2009mg\/day methylprednisolone for 3\u2009days or plasmapheresis with 1000\u2009mg\/day methylprednisolone for 3\u2009days. Recruitment will consist of 28 participants to each arm of the trial. Diagnosis will be confirmed by\n                      <jats:italic>Leptospira<\/jats:italic>\n                      -specific PCR and microscopic agglutination test. Analysis will follow intention-to-treat principles with adjustment for multiple comparisons. Primary outcome is all-cause mortality at 28 days. Secondary outcomes include hospital-acquired infections, duration of respiratory support, duration of intensive care unit stay, duration of hospital stay and side effects of steroid therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The ethical approval was obtained from the Research Ethics Committee of the University of Sri Jayewardenepura (ERC 20\/24) and the trial has been registered in the Sri Lanka Clinical Trials Registry (SLCTR\/2024\/037). Trial is approved by the National Medicines Regulatory Authority in Sri Lanka (NMRA\/CTRD\/PA4\/54). Study findings will be disseminated through peer-reviewed publications and conference presentations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>Sri Lanka Clinical Trials Registry, Number SLCTR\/2024\/037.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-119234","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:05:53Z","timestamp":1785758753000},"page":"e119234","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Multicentre open-label randomised controlled trial to evaluate the efficacy and safety of moderate-dose and high-dose intravenous methylprednisolone combined with plasmapheresis versus plasmapheresis alone in leptospirosis pulmonary haemorrhage syndrome: a protocol"],"prefix":"10.1136","volume":"16","author":[{"given":"K A","family":"Yeshinika","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senara","family":"Vidanapathirana","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Rambukwella","sequence":"additional","affiliation":[{"name":"Central Province, Department of Health Services, Kandy, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wimalasiri","family":"Uluwattage","sequence":"additional","affiliation":[{"name":"National Hospital Galle, Galle, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushka D","family":"Mudalige","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, Colombo North Teaching Hospital, Ragama, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasanee","family":"Wanigasuriya","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Colombo South Teaching Hospital, Kalubowila, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandima","family":"Jeewandara","sequence":"additional","affiliation":[{"name":"Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka"},{"name":"Institute of Allergology and Immunology, University of Sri Jayewardenepura, Nugegoda, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilshan","family":"Priyankara","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0154-1864","authenticated-orcid":false,"given":"Nilanka","family":"Perera","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"2026090400402198000_16.8.e119234.1","unstructured":"Brito TD . Commented review. Journal Sao Paulo Inst Trop Med 2018;1\u201310."},{"key":"2026090400402198000_16.8.e119234.2","doi-asserted-by":"crossref","unstructured":"Costa F , Hagan JE , Calcagno J , et al . Global morbidity and mortality of leptospirosis: a systematic review. PLoS Negl Trop Dis 2015;9. doi:10.1371\/journal.pntd.0003898","DOI":"10.1371\/journal.pntd.0003898"},{"key":"2026090400402198000_16.8.e119234.3","doi-asserted-by":"crossref","unstructured":"Sato H , Coburn J . Leptospira interrogans causes quantitative and morphological disturbances in adherens junctions and other biological groups of proteins in human endothelial cells. PLoS Negl Trop Dis 2017;11. doi:10.1371\/journal.pntd.0005830","DOI":"10.1371\/journal.pntd.0005830"},{"key":"2026090400402198000_16.8.e119234.4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-45059-8_5"},{"key":"2026090400402198000_16.8.e119234.5","doi-asserted-by":"crossref","unstructured":"Raffray L , Giry C , Thirapathi Y , et al . Increased levels of soluble forms of E-selectin and ICAM-1 adhesion molecules during human leptospirosis. PLoS One 2017;12. doi:10.1371\/journal.pone.0180474","DOI":"10.1371\/journal.pone.0180474"},{"key":"2026090400402198000_16.8.e119234.6","doi-asserted-by":"crossref","unstructured":"Warnasekara J , Koralegedara I , Agampodi S . Estimating the burden of leptospirosis in Sri Lanka; a systematic review. BMC Infect Dis 2019;19. doi:10.1186\/s12879-018-3655-y","DOI":"10.1186\/s12879-018-3655-y"},{"key":"2026090400402198000_16.8.e119234.7","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4094-0"},{"key":"2026090400402198000_16.8.e119234.8","doi-asserted-by":"publisher","DOI":"10.1111\/J.1469-0691.2009.03037.X"},{"key":"2026090400402198000_16.8.e119234.9","unstructured":"National guidelines on management of leptospirosis epidemiology unit ministry of health, nutrition and indigenous medicine Sri Lanka [internet]. 2016. Available: www.epid.gov.lk"},{"key":"2026090400402198000_16.8.e119234.10","doi-asserted-by":"crossref","unstructured":"Ruwanpathirana P , Rambukwella R , Perera N , et al . Severe leptospirosis in the intensive care unit: single centre prospective cohort study from Sri Lanka. BMC Infect Dis 2026;26. doi:10.1186\/s12879-025-12477-y","DOI":"10.1186\/s12879-025-12477-y"},{"key":"2026090400402198000_16.8.e119234.11","doi-asserted-by":"crossref","unstructured":"Fonseka CL , Dahanayake NJ , Mihiran DJD , et al . Pulmonary haemorrhage as a frequent cause of death among patients with severe complicated Leptospirosis in Southern Sri Lanka. PLoS Negl Trop Dis 2023;17. doi:10.1371\/journal.pntd.0011352","DOI":"10.1101\/2023.05.04.23289495"},{"key":"2026090400402198000_16.8.e119234.12","unstructured":"Jamovi 01 [internet]. n.d. Available: https:\/\/www.jamovi.org"},{"key":"2026090400402198000_16.8.e119234.13","unstructured":"Jamovi 2 [internet]. n.d. Available: https:\/\/cran.r-project.org"},{"key":"2026090400402198000_16.8.e119234.14","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780090612"},{"key":"2026090400402198000_16.8.e119234.15","doi-asserted-by":"crossref","unstructured":"Wittes J . Sample size calculations 401 for randomized controlled trials [internet]. 2002. Available: https:\/\/academic.oup.com\/epirev\/article\/24\/1\/39\/2754707","DOI":"10.1093\/epirev\/24.1.39"},{"key":"2026090400402198000_16.8.e119234.16","doi-asserted-by":"crossref","unstructured":"Silva L da , Carneiro MC , Lorga ACM , et al . Leptospirosis-associated pulmonary hemorrhagic syndrome: immune mechanisms, clinical manifestations, and experimental models. Rev Inst Med Trop Sao Paulo 2026;68. doi:10.1590\/S1678-9946202668009","DOI":"10.1590\/s1678-9946202668009"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-119234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:40:33Z","timestamp":1788507633000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-119234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":16,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,3]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bmjopen-2026-119234"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-119234","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}